| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1177/106002809402800912 |
| P698 | PubMed publication ID | 7803884 |
| P2093 | author name string | D F Thompson | |
| C F Seifert | |||
| M E Nesser | |||
| P2860 | cites work | Pharmacokinetics of the cardioprotector ADR-529 (ICRF-187) in escalating doses combined with fixed-dose doxorubicin | Q28317288 |
| Reducing doxorubicin cardiotoxicity in the rat using deferred treatment with ADR-529 | Q28320156 | ||
| ICRF-187 permits longer treatment with doxorubicin in women with breast cancer | Q28324350 | ||
| Risk factors for doxorubicin-induced congestive heart failure | Q28328220 | ||
| Effect of ICRF-187 pretreatment against doxorubicin-induced delayed cardiotoxicity in the rat | Q28329176 | ||
| A prospective randomized trial of ICRF-187 for prevention of cumulative doxorubicin-induced cardiac toxicity in women with breast cancer | Q28329748 | ||
| Adriamycin and Radiation: Synergistic Cardiotoxicity | Q28341547 | ||
| Effect of ICRF-187 on doxorubicin-induced myocardial effects in the mouse and guinea pig | Q28367382 | ||
| Doxorubicin cardiotoxicity may be caused by its metabolite, doxorubicinol | Q33575389 | ||
| Doxorubicin selectively inhibits muscle gene expression in cardiac muscle cells in vivo and in vitro | Q33614685 | ||
| Glutathione: interorgan translocation, turnover, and metabolism | Q33979283 | ||
| Enzymatic defenses of the mouse heart against reactive oxygen metabolites: alterations produced by doxorubicin | Q34718010 | ||
| Toxicity profile of dexrazoxane (zinecardR, icrf-187, adr-529, nsc-169780), a modulator of doxorubicin cardiotoxicity | Q37143331 | ||
| Doxorubicin (adriamycin): a critical review of free radical-dependent mechanisms of cytotoxicity | Q37949829 | ||
| A new insight into adriamycin-induced cardiotoxicity | Q38012571 | ||
| The anthracycline antineoplastic drugs | Q40308244 | ||
| Phase I study of doxorubicin, ICRF-187 and granulocyte/macrophage-colony-stimulating factor | Q40738694 | ||
| Protective effect of the bispiperazinedione ICRF-187 against doxorubicin-induced cardiac toxicity in women with advanced breast cancer | Q40783194 | ||
| Amelioration of chronic anthracycline cardiotoxicity by ICRF-187 and other compounds | Q42208727 | ||
| Inhibition of doxorubicin-initiated membrane damage by N-acetylcysteine: possible mediation by a thiol-dependent, cytosolic inhibitor of lipid peroxidation | Q42210542 | ||
| Early changes in human myocardial nuclei after doxorubicin | Q42259964 | ||
| Reduction of doxorubicin cardiotoxicity by prolonged continuous intravenous infusion | Q42263291 | ||
| Lethal and sublethal effects of the combination of doxorubicin and the bisdioxopiperazine, (+)-1,2,-bis (3-5-dioxopiperazinyl-1-yl) propane (ICRF 187), on murine sarcoma S180 in vitro | Q45072345 | ||
| Might adriamycinol contribute to adriamycin-induced cardiotoxicity? | Q53832898 | ||
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | prevention | Q1717246 |
| P304 | page(s) | 1063-1072 | |
| P577 | publication date | 1994-09-01 | |
| P1433 | published in | Annals of Pharmacotherapy | Q4767858 |
| P1476 | title | Dexrazoxane in the prevention of doxorubicin-induced cardiotoxicity | |
| P478 | volume | 28 |
| Q89231551 | A Doxorubicin-induced Cardiomyopathy Model in Adult Zebrafish |
| Q37052852 | A recommended practical approach to the management of anthracycline-based chemotherapy cardiotoxicity: an opinion paper of the working group on drug cardiotoxicity and cardioprotection, Italian Society of Cardiology |
| Q33963576 | Adriamycin-induced heart failure: mechanism and modulation |
| Q35100669 | Altered responsiveness of the guinea-pig isolated ileum to smooth muscle stimulants and to electrical stimulation after in situ ischemia |
| Q74423004 | Anthracycline-induced acute cardiotoxicity in adults treated for leukaemia. Analysis of the clinico-pathological aspects of documented acute anthracycline-induced cardiotoxicity in patients treated for acute leukaemia at the University Hospital of Z |
| Q53428348 | Antioxidant inhibitors for cancer therapy. |
| Q46805568 | Cardioprotective effects of fullerenol C(60)(Oh)(24) on a single dose doxorubicin-induced cardiotoxicity in rats with malignant neoplasm |
| Q36174517 | Cardiotoxicity of cancer chemotherapy: implications for children |
| Q42538440 | Cardiotoxicity of doxorubicin: effects of 21-aminosteroids |
| Q46592609 | Carfilzomib-induced cardiotoxicity mitigated by dexrazoxane through inhibition of hypertrophic gene expression and oxidative stress in rats |
| Q36126521 | Dexrazoxane : a review of its use for cardioprotection during anthracycline chemotherapy |
| Q27345163 | Dexrazoxane Diminishes Doxorubicin-Induced Acute Ovarian Damage and Preserves Ovarian Function and Fecundity in Mice |
| Q44389042 | Doxorubicin cardiotoxicity: prevention of congestive heart failure with serial cardiac function monitoring with equilibrium radionuclide angiocardiography in the current era. |
| Q92677814 | Doxorubicin-Induced Cardiomyopathy in Children |
| Q34773776 | Doxorubicin-induced apoptosis: implications in cardiotoxicity |
| Q64104933 | Exosomal delivery of doxorubicin enables rapid cell entry and enhanced in vitro potency |
| Q38219831 | Historical perspective on the introduction and use of chemotherapy for the treatment of osteosarcoma |
| Q90653004 | In Vivo Reactive Oxygen Species Detection With a Novel Positron Emission Tomography Tracer, 18F-DHMT, Allows for Early Detection of Anthracycline-Induced Cardiotoxicity in Rodents |
| Q41669706 | Melatonin Supplementation Ameliorates Energy Charge and Oxidative Stress Induced by Acute Exercise in Rat Heart Tissue |
| Q44558496 | Melatonin stimulates the activity of protective antioxidative enzymes in myocardial cells of rats in the course of doxorubicin intoxication |
| Q42153380 | Metformin rescues the myocardium from doxorubicin-induced energy starvation and mitochondrial damage in rats |
| Q35009418 | Minimising the long-term adverse effects of childhood leukaemia therapy |
| Q33982934 | Ozone-Oxidative Preconditioning Prevents Doxorubicin-induced Cardiotoxicity in Sprague-Dawley Rats |
| Q42861882 | Phenylbutyrate, a histone deacetylase inhibitor, protects against Adriamycin-induced cardiac injury |
| Q24791372 | Protection against acute adriamycin-induced cardiotoxicity by garlic: role of endogenous antioxidants and inhibition of TNF-alpha expression |
| Q50082485 | Redox Paradox: A novel approach to therapeutics-resistant cancer |
| Q44086407 | Role of exogenous melatonin in reducing the nephrotoxic effect of daunorubicin and doxorubicin in the rat. |
| Q35852267 | Rust and corrosion in hematopoietic stem cell transplantation: the problem of iron and oxidative stress |
| Q37950516 | Systemic management strategies for metastatic soft tissue sarcoma. |
| Q36514299 | The Current and Future Therapies for Human Osteosarcoma |
| Q33427938 | The minipig as a new model for the evaluation of doxorubicin-induced chronic toxicity |
| Q38207452 | The role of anthracyclines in the treatment of early breast cancer |
| Q74601644 | Thermal preconditioning protects rat cardiac muscle cells from doxorubicin-induced apoptosis |
| Q49832269 | Topoisomerases as anticancer targets |
| Q73181060 | [The prevention of anthracycline-induced cardiomyopathy with a chelating agent (dexrazoxane = ICRF-187)] |
Search more.